CDKN2A and cancer: An antiapoptotic role played by p16 has been shown to be associated with downregulation of proapoptotic proteins such as Bax‐Bak and cell cycle regulator Bcl‐2, and sensitization of proliferating cancer cells to cisplatin activity.26